Pritesh Shah
Net worth: 1 M $ as of 2024-04-29
Profile
Pritesh Shah worked as a Marketing Director for the Oncology Pipeline at OSI Pharmaceuticals, Inc. He then served as the Chief Growth Officer at NovoCure Ltd.
from 2022 to 2024.
Dr. Shah holds a graduate degree from Seton Hall University and a doctorate from the University of Maryland.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD.
0.11% | 2024-04-01 | 119,794 ( 0.11% ) | 1 M $ | 2024-04-29 |
Former positions of Pritesh Shah
| Companies | Position | End |
|---|---|---|
| NOVOCURE LIMITED | Corporate Officer/Principal | 2023-12-31 |
| OSI PHARMACEUTICALS, INC. | Sales & Marketing | - |
Training of Pritesh Shah
| University of Maryland | Doctorate Degree |
| Seton Hall University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NOVOCURE LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
- Stock Market
- Insiders
- Pritesh Shah
